Refine Search
(22)
(30)
(32)
(33)

Gastric Ulcers - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastric Ulcers - Pipeline Review, H2 2018’, provides an overview of the Gastric Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastric Ulcers, ...

Pancreatitis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pancreatitis - Pipeline Review, H2 2018’, provides an overview of the Pancreatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pancreatitis, comple...

Alcoholic Hepatitis - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H2 2018’, provides an overview of the Alcoholic Hepatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alcoho...

Celiac Disease - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H2 2018’, provides an overview of the Celiac Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Celiac Disease, ...

Liver Cirrhosis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Liver Cirrhosis - Pipeline Review, H2 2018’, provides an overview of the Liver Cirrhosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Liver Cirrhosi...

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2018’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

The report provides comprehensive information on the...

Oral Mucositis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oral Mucositis - Pipeline Review, H2 2018’, provides an overview of the Oral Mucositis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Oral Mucositis, ...

Diabetic Gastroparesis - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Gastroparesis - Pipeline Review, H2 2018’, provides an overview of the Diabetic Gastroparesis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2018’, provides an overview of the Non-Alcoholic Steatohepatitis (NASH) pipeline landscape.

The report provides comprehensive information on the therape...

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2018’, provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD) pipeline landscape.

The report provides comprehensive information on t...

Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2018’, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Urem...

Primary Sclerosing Cholangitis - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Sclerosing Cholangitis - Pipeline Review, H2 2018’, provides an overview of the Primary Sclerosing Cholangitis pipeline landscape.

The report provides comprehensive information on the therapeutics under ...

Primary Biliary Cirrhosis - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Primary Biliary Cirrhosis - Pipeline Review, H2 2018’, provides an overview of the Primary Biliary Cirrhosis pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2018’, provides an overview of the Functional (Non Ulcer) Dyspepsia pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Colitis - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colitis - Pipeline Review, H2 2018’, provides an overview of the Colitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysi...